SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Rockley Photonics Holdings Limited – RKLY; RKLY.W
NEW YORK, Nov. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited (“Rockley” or the “Company”) (NASDAQ: RKLY; RKLY.W). Such investors are advised to contact Robert S. Willoughby at newaction@poml
SeatCash Inc. Announces the Beta Launch of FareX.ai: The Next Generation Airfare Prediction Tool
CHICAGO, Nov. 28, 2023 /PRNewswire/ — SeatCash Inc., a leader in travel technology innovation is excited to announce the launch of FareX.ai, its proprietary airfare prediction tool. FareX.ai is designed to empower both businesses managing air travel procurement and individual travelers by prov
Navigating the Evolving Market Dynamics of Bone Sarcoma: A Comprehensive Analysis of Osteosarcoma, Ewing Sarcoma, and Chondrosarcoma | DelveInsight
Each individual’s risk of being diagnosed with primary bone sarcoma and their chances of recovery following diagnosis are influenced by a range of unique factors. In 2023, it is anticipated that 4K individuals of all ages in the United States will be diagnosed with primary bone sarcoma, includ
Humanforce Announces Strategic Partnership with Pinpoint HRM: Delivering Exceptional Customer Experiences for Frontline Workforces
SYDNEY, Nov. 29, 2023 /PRNewswire/ — Humanforce, an Australian-borne global provider of human capital management (HCM) solutions, today announced a new strategic partnership with Pinpoint HRM, leading HR technology project experts in the A/NZ region. This strategic partnership brings together
ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS SECOND QUARTER OF FISCAL YEAR 2024
Net earnings were $819.2 million, or $0.85 per diluted share for the second quarter of fiscal 2024 compared with $810.4 million, or $0.79 per diluted share for the second quarter of fiscal 2023. Adjusted net earnings1 were approximately $792.0 million compared with $838.0 million for the second quar
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
The metastatic non-small cell lung cancer market size is expected to witness a revolutionary change in the coming decade owing to the increase in incident cases of NSCLC, continuous uptake of approved therapies, expected entry of potential premium price emerging therapies, and increasing awareness o
TCL Giving Away $1M in 98″ TVs Following 99-Yard Touchdown During Inaugural NFL Black Friday Game
Leading Electronics Brand Awards Big Screen TVs to Sweepstakes Entrants in “Ultimate Gameday Upgrade” IRVINE, Calif., Nov. 28, 2023 /PRNewswire/ — TCL®’s $1,000,000 prize – the largest purse in its Ultimate Gameday Upgrade sweepstakes – was officially unlocked in the ina
The Future of Industrial Automation – Technology Convergence, Edge Computing, AI/ML, Robots, and Autonomous Systems Create New Growth Opportunities
DUBLIN, Nov. 28, 2023 /PRNewswire/ — The “Future of Industrial Automation: An Overview of Sensors and Transmitters and Liquid Analyzers” report has been added to ResearchAndMarkets.com’s offering. This study analyzes key industrial automation market metrics and trends, offer
The Harvard Medical School Master of Science in Media, Medicine, and Health program presents Portraying HIV & AIDS in the Media: How Far Have We Come?
CAMBRIDGE, Mass., Nov. 28, 2023 /PRNewswire/ — The Master of Science in Media, Medicine, and Health program, led by Neal Baer, MD and Jason Silverstein, PhD, will present a panel discussion: Portraying HIV & AIDS in the Media: How Far Have We Come? on Friday, December 1, 4:30pm-6:00pm ET.
Pleasantrees Reaches Cannabis Milestone with 200th Harvest
The Leading Michigan Retailer has Harvested 87,000 Plants for Medical and Recreational Use Since 2020 HARRISON TOWNSHIP, Mich., Nov. 28, 2023 /PRNewswire/ — Pleasantrees today announces its 200th cannabis harvest. This milestone comes five years after recreational cannabis sales became legal i
